JOIN US
Leaders shaping our 2025 program:
Natalie Artzi, PhD, Associate Professor, Brigham and Women’s Hospital, Harvard Medical School
Ryan Brady, Head of Global Discovery Business Development, Evotec
Michael Chen, PhD, Co-Founder and CSO, Seaport Therapeutics
Kevin Churchwell, MD, President/CEO, Boston Children’s Hospital
Steve Dickman, CEO, CBT Advisors
Rahul Dhanda, Co-Founder, President & CEO, Syntis Bio
Michael Gilman, PhD, CEO, Arrakis Therapeutics
Sam Kulkarni, PhD, CEO, CRISPR Therapeutics
Liz Leveille, VP, Business Dev. & Licensing, Head, Boston & European Innovation Hubs & Discovery Transactions, Merck
Ivana Magovcevic-Liebisch, PhD, CEO and President, Vigil Neuroscience
Phil McGurk, PhD, SVP, Head of Corporate Development, Takeda
Jodie Morrison, Venture Partner, Atlas Venture
Marian Nakada, PhD, VP of Venture Investments, Johnson & Johnson Innovation - JJDC
Andy Plump, MD, PhD, President, Research & Development, Takeda
Liz Powell, Founder, G2G Consulting; Co-Founder, Women's Digital Health Network & Breast Cancer Early Detection Coalition
Rosemary Reilly, Partner, WilmerHale
Dave Reshef, MD, PhD, Venture Partner, GV
Josh Resnick, MD, Partner, RA Capital Management
John Stanford, Executive Director, Incubate Coalition
Steve Sweeney, President and Chief Operating Officer, Aliada Therapeutics (acquired by Abbvie)
Alison Taunton-Rigby OBE, PhD, Independent Director, CEO, and Entrepreneur, Life Science & Healthcare Organizations,
Ramani Varanasi, Managing Director, ReVive Advisors